Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose range finding study of formoterol fumarate via Ultrahaler in asthma
2005-001740-24Phase 2Completed
- Sponsor
- Altana Pharma
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of formoterol in asthma (3 arms), sponsored by Altana Pharma. Primary endpoints: Efficacy variables and Safety and tolerability. Started Jun 2006; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-001740-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001740-24.